PCM
Peregrine Capital Management Portfolio holdings
AUM
$3.32B
1-Year Return
23.17%
This Quarter Return
+8.5%
1 Year Return
+23.17%
3 Year Return
+97.35%
5 Year Return
+164.6%
10 Year Return
–
AUM
$3.49B
AUM Growth
+$162M
(+4.9%)
Cap. Flow
-$70.4M
Cap. Flow
% of AUM
-2.02%
Top 10 Holdings %
Top 10 Hldgs %
23.61%
Holding
339
New
21
Increased
97
Reduced
142
Closed
20
Top Buys
| 1 |
Mobileye
MBLY
|
$34.7M |
| 2 |
Neogen
NEOG
|
$8.9M |
| 3 |
Patrick Industries
PATK
|
$8.55M |
| 4 |
On Holding
ONON
|
$7.94M |
| 5 |
American Healthcare REIT
AHR
|
$7.76M |
Top Sells
| 1 |
HEICO
HEI
|
$28.4M |
| 2 |
BILL Holdings
BILL
|
$21.1M |
| 3 |
Collegium Pharmaceutical
COLL
|
$10.6M |
| 4 |
DOOR
MASONITE INTERNATIONAL CORP
DOOR
|
$9.24M |
| 5 |
Permian Resources
PR
|
$9.15M |
Sector Composition
| 1 | Technology | 25.06% |
| 2 | Healthcare | 17.32% |
| 3 | Financials | 15.38% |
| 4 | Consumer Discretionary | 14.42% |
| 5 | Industrials | 10.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Apellis Pharmaceuticals
APLS
$3.62B
| $5.45M | 0.16% |
+92,660
| New | +$5.45M |
|
227
Astec Industries
ASTE
$1.07B
| $5.45M | 0.16% |
124,597
+11,956
| +11% | +$523K |
|
228
BioLife Solutions
BLFS
$1.24B
| $5.45M | 0.16% |
293,587
+100
| +0% | +$1.86K |
|
229
Helen of Troy
HELE
$588M
| $5.44M | 0.16% |
47,243
-2,845
| -6% | -$328K |
|
|
ZUO
230
DELISTED
Zuora, Inc.
ZUO
| $5.38M | 0.15% |
590,128
+196
| +0% | +$1.79K |
|
231
ADMA Biologics
ADMA
$4.04B
| $5.38M | 0.15% |
815,044
-67,939
| -8% | -$448K |
|
|
LGF.B
232
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $5.24M | 0.15% |
562,383
+195
| +0% | +$1.82K |
|
233
Enterprise Financial Services Corp
EFSC
$2.26B
| $5.2M | 0.15% |
128,325
-7,781
| -6% | -$316K |
|
234
MarineMax
HZO
$559M
| $5.2M | 0.15% |
156,344
-9,264
| -6% | -$308K |
|
235
RB Global
RBA
$21.5B
| $5.19M | 0.15% |
68,120
+55
| +0.1% | +$4.19K |
|
236
Ionis Pharmaceuticals
IONS
$9.46B
| $5.14M | 0.15% |
118,598
+10,774
| +10% | +$467K |
|
237
Syndax Pharmaceuticals
SNDX
$1.39B
| $4.67M | 0.13% |
196,079
+46
| +0% | +$1.1K |
|
238
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $4.66M | 0.13% |
+236,045
| New | +$4.66M |
|
239
Frontier Group Holdings
ULCC
$1.18B
| $4.65M | 0.13% |
573,886
-34,539
| -6% | -$280K |
|
240
Sarepta Therapeutics
SRPT
$1.93B
| $4.6M | 0.13% |
35,514
-2,949
| -8% | -$382K |
|
|
ALTM
241
DELISTED
Arcadium Lithium plc
ALTM
| $4.43M | 0.13% |
+1,028,490
| New | +$4.43M |
|
|
ATSG
242
DELISTED
Air Transport Services Group, Inc.
ATSG
| $3.99M | 0.11% |
289,969
-17,489
| -6% | -$241K |
|
243
Stoneridge
SRI
$234M
| $3.94M | 0.11% |
213,596
-12,586
| -6% | -$232K |
|
|
LUCK
244
Lucky Strike Entertainment Corporation
LUCK
$1.46B
| $3.72M | 0.11% |
271,627
+64
| +0% | +$877 |
|
245
InMode
INMD
$910M
| $3.69M | 0.11% |
170,830
-114,722
| -40% | -$2.48M |
|
246
Monro
MNRO
$515M
| $2.93M | 0.08% |
92,915
+39
| +0% | +$1.23K |
|
247
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $2.43M | 0.07% |
1,016,455
-73,506
| -7% | -$176K |
|
248
Manhattan Associates
MANH
$12.7B
| $2.13M | 0.06% |
8,510
| – | – |
|
249
WESCO International
WCC
$10.6B
| $1.75M | 0.05% |
10,218
+1,300
| +15% | +$223K |
|
250
Novanta
NOVT
$4.15B
| $1.54M | 0.04% |
8,838
| – | – |
|